Cours Vitality Biopharma, Inc. Other OTC
Actions
VBIO
US92849B1070
Services et équipements environnementaux
CA 2022 | 4,83 M 4,37 M | CA 2023 | 19,35 M 17,5 M | Capitalisation | 27,28 M 24,67 M |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -905 k | Résultat net 2023 | 3 M 2,71 M | VE / CA 2022 | 3,86 x |
Dette nette 2022 | 4,61 M 4,17 M | Dette nette 2023 | 8,23 M 7,44 M | VE / CA 2023 | 1,84 x |
PER 2022 |
-11,4
x | PER 2023 |
7,17
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 53,01% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 50 | 15/11/18 | |
Patricia Missal
DFI | Director of Finance/CFO | 55 | 01/06/23 |
Rebecca Wharton
HRO | Human Resources Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Edward Feighan
CHM | Chairman | 76 | 15/11/18 |
Chief Executive Officer | 50 | 15/11/18 | |
Richard Celeste
BRD | Director/Board Member | 86 | 24/01/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,09% | 83,38 Md | |
+12,47% | 58,42 Md | |
+18,82% | 11,18 Md | |
+24,45% | 11,11 Md | |
-7,97% | 6,29 Md | |
+27,47% | 4,92 Md | |
+13,71% | 4,61 Md | |
-5,29% | 3 Md | |
-1,80% | 2,45 Md |